Literature DB >> 748091

Analysis of human pure pancreatic juice in chronic pancreatitis and cancer of the pancreas.

H Harada, T Hayashi, A Ono, N Yamamoto, I Ikubo, T Shundo, A Negron, K Mishima, I Kimura.   

Abstract

Pure pancreatic juice was collected from 8 control subjects, 12 patients with chronic pancreatitis and 4 patients with cancer of the pancreas by endoscopic retrograde cannulation of the papilla. Samples were collected at 1 minute intervals for 20 minutes after rapid intravenous injection of secretin (Eisai, 1 U/kg) and for 10 minutes after rapid intravenous injection of CCK-PZ (Boots, 1 U/kg). Determinations of volume, bicarbonate concentration and three hydrolases (amylase, chymotrypsinogen and lipase) were made. Our tentative conclusions are (1) pancreatic enzymes are likely to be affected one after another, not in parallel fashing, in chronic pancreatitis and in cancer of the pancreas, (2) bicarbonate concentration and chymotrypsinogen or lipase are most susceptible in chronic pancreatitis and lipase secretion seems to be more susceptible than other parameters in cancer of the pancreas. Amylase is the least affected enzyme in both pancreatic diseases, and (3) determinations of chymotrypsinogen and/or lipase should be preferably performed among hydrolytic enzymes in the evaluation of exocrine pancreatic function in chronic pancreatitis and cancer of the pancreas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748091     DOI: 10.1007/bf02774912

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  18 in total

1.  [A new test of exocrine pancreatic function using N-benzoyl-L-tyrosyl-p-aminobenzoic acid. Part II. The correlation of PFD and chymotrypsin output during PS-test (author's transl)].

Authors:  K Kinugasa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1977-10

2.  The interrelationships of pancreatic enzymes in health and diseases under cholecystokinin stimulation.

Authors:  Y Minaire; L Descos; J P Daly; M B Bererd; R Lambert
Journal:  Digestion       Date:  1973       Impact factor: 3.216

3.  Trypsin and chymotrypsin as aids in the diagnosis of pancreatic disease.

Authors:  D M Goldberg; J K Sale; N Fawcett; K G Wormsley
Journal:  Am J Dig Dis       Date:  1972-09

4.  Inhibitory action of alcohol on human exocrine pancreatic secretion.

Authors:  C Mott; H Sarles; O Tiscornia; L Gullo
Journal:  Am J Dig Dis       Date:  1972-10

5.  The exocrine pancreas and protein-calorie malnutrition.

Authors:  G O Barbezat; J D Hansen
Journal:  Pediatrics       Date:  1968-07       Impact factor: 7.124

6.  Diagnostic value of fecal chymotrypsin and trypsin assessment for detection of pancreatic disease. A comparative study.

Authors:  R W Ammann; E Tagwecher; H Kashiwagi; H Rosenmund
Journal:  Am J Dig Dis       Date:  1968-02

7.  [Clinical-functional diagnosis of pancreas carcinoma. With special consideration of the pancreozymin-secretin test and proteolytic stool enzyme activity].

Authors:  L Filippini; R Ammann
Journal:  Schweiz Med Wochenschr       Date:  1967-06-24

8.  Secretion of pancreatic enzymes. I. Response to secretin and pancreozymin.

Authors:  L Zieve; S E Silvis; B Mulford; W D Blackwood
Journal:  Am J Dig Dis       Date:  1966-09

9.  A diagnostic approach to inflammatory disease of the pancreas by means of endoscopic retrograde cholangio-pancreatography.

Authors:  H Harada; J Tanaka; T Shundo; T Hayashi; T Sasaki; N Yamamoto; T Sato; K Mishima; I Kimura
Journal:  Gastroenterol Jpn       Date:  1977

10.  A test of pancreatic function in man based on the analysis of duodenal contents after administration of secretin and pancreozymin.

Authors:  P BURTON; D G EVANS; A A HARPER; T HOWATH; S OLEESKY; J E SCOTT; H VARLEY
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

View more
  10 in total

Review 1.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Exocrine pancreatic function test by endoscopic retrograde aspiration of pure pancreatic juice.

Authors:  K Ochi; H Harada; J Tanaka; T Ishibashi; H Oka; H Miyake; I Kimura
Journal:  Gastroenterol Jpn       Date:  1988-06

3.  Analysis of pure pancreatic juice in patients with chronic alcoholism.

Authors:  H Harada; H Yabe; E Hanafusa; I Ikubo; M Takeda; T Hayashi; A Negron; A Ono; N Yamamoto; K Mishima; I Kimura
Journal:  Gastroenterol Jpn       Date:  1979-10

4.  Studies on the effect of glucagon on human pancreatic secretion by analysis of endoscopically obtained pure pancreatic juice.

Authors:  H Harada; F Kochi; E Hanafusa; T Kobayashi; H Oka; I Kimura
Journal:  Gastroenterol Jpn       Date:  1985-02

5.  The calcium concentration in human pure pancreatic juice in chronic pancreatitis.

Authors:  H Harada; M Takeda; H Yabe; E Hanafusa; T Hayashi; K Kunichika; F Kochi; K Mishima; I Kimura
Journal:  Gastroenterol Jpn       Date:  1980

6.  Human pancreatic secretory protein profiles in the search for tumor markers.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

7.  The hexosamine concentration and output in human pure pancreatic juice in chronic pancreatitis.

Authors:  H Harada; M Takeda; H Yabe; E Hanafusa; T Hayashi; K Kunichika; F Kochi; K Mishima; I Kimura; T Ubuga
Journal:  Gastroenterol Jpn       Date:  1980

8.  Detection of c-Ki-ras point mutation from pancreatic juice. A useful diagnostic approach for pancreatic carcinoma.

Authors:  H Miki; S Matsumoto; H Harada; S Mori; R Haba; K Ochi; S Kobayashi; M Ohmori
Journal:  Int J Pancreatol       Date:  1993-10

9.  Secretory component and lactoferrin in pure pancreatic juice in chronic pancreatitis.

Authors:  T Hayakawa; T Kondo; T Shibata; T Murase; H Harada; K Ochi; J Tanaka
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

10.  Effects of chronic alcohol abuse on exocrine pancreatic secretion in man.

Authors:  H Rinderknecht; N H Stace; I G Renner
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.